Plasma fibrinogen level as possible prognostic biomarker in diffuse large B-cell lymphoma

Ratio of Immune Response to Tumor Burden Predicts Survival Via Regulating Functions of Lymphocytes and Monocytes in Diffuse Large B-Cell Lymphoma

(2018) Hongfei Ji et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

A Novel Inflammation-Based Prognostic Score: The Fibrinogen/Albumin Ratio Predicts Prognoses of Patients after Curative Resection for Hepatocellular Carcinoma

(2018) Qiaodong Xu et al.   Journal of Immunology Research

Prognostic role of plasma fibrinogen in patients with uterine leiomyosarcoma – a multicenter study

(2017) Christine Bekos et al.   Scientific Reports

Loss of RUNX3 expression is an independent adverse prognostic factor in diffuse large B-cell lymphoma

(2016) Virginia E. Duncan et al.   LEUKEMIA & LYMPHOMA

Estrogen receptor β1 in diffuse large B-cell lymphoma growth and as a prognostic biomarker

(2016) Muhammad Sharif Hasni et al.   LEUKEMIA & LYMPHOMA

Clinical and Prognostic Significance of Preoperative Plasma Fibrinogen Levels in Patients with Operable Breast Cancer

(2016) Yu Mei et al.   PLoS One

Clinical significance of plasma fibrinogen and D-dimer in predicting the chemotherapy efficacy and prognosis for small cell lung cancer patients

(2015) L.-R. Zhu et al.   Clinical & Translational Oncology

The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma

(2015) Katharina T Troppan et al.   JOURNAL OF CLINICAL PATHOLOGY

Peripheral blood lymphocyte/monocyte ratio at the time of first relapse predicts outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma

(2014) Yan-Li Li et al.   BMC CANCER

Chronic Inflammation and Cytokines in the Tumor Microenvironment

(2014) Glauben Landskron et al.   Journal of Immunology Research

Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients – analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO

(2009) Rohini Sharma et al.   BMC CANCER

Plasma Fibrinogen Levels and Prognosis in Patients with Ovarian Cancer: A Multicenter Study

(2009) S. Polterauer et al.   ONCOLOGIST